Pavion Blue Capital’s Bristol-Myers Squibb BMY Stock Holding History

Pavion Blue Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$862K	Sell	14,208 -25	-0.2%	-$1.46K	0.37%	54
2025 Q4	$768K	Sell	14,233 -1,000	-7%	-$48.1K	0.32%	54
2025 Q3	$687K	Hold	15,233	–	–	0.29%	59
2025 Q2	$705K	Hold	15,233	–	–	0.31%	58
2025 Q1	$929K	Hold	15,233	–	–	0.44%	47
2024 Q4	$862K	Buy	15,233 +1,000	+7%	+$55.9K	0.4%	48
2024 Q3	$736K	Hold	14,233	–	–	0.34%	57
2024 Q2	$591K	Hold	14,233	–	–	0.29%	61
2024 Q1	$772K	Sell	14,233 -2,143	-13%	-$109K	0.38%	54
2023 Q4	$840K	Hold	16,376	–	–	0.46%	52
2023 Q3	$950K	Hold	16,376	–	–	0.58%	46
2023 Q2	$1.05M	Hold	16,376	–	–	0.61%	44
2023 Q1	$1.14M	Hold	16,376	–	–	0.7%	40
2022 Q4	$1.18M	Buy	16,376 +25	+0.2%	+$1.89K	0.75%	40
2022 Q3	$1.16M	Hold	16,351	–	–	0.83%	34
2022 Q2	$1.26M	Buy	16,351 +102	+0.6%	+$7.77K	0.85%	35
2022 Q1	$1.19M	Buy	16,249 +50	+0.3%	+$3.36K	0.7%	37
2021 Q4	$1.01M	Sell	16,199 -121	-0.7%	-$7.1K	0.59%	41
2021 Q3	$966K	Buy	16,320 +350	+2%	+$23.1K	0.6%	42
2021 Q2	$1.07M	Hold	15,970	–	–	0.64%	41
2021 Q1	$1.01M	Hold	15,970	–	–	0.66%	40
2020 Q4	$991K	Sell	15,970 -69	-0.4%	-$4.24K	0.68%	38
2020 Q3	$967K	Hold	16,039	–	–	0.74%	37
2020 Q2	$943K	Buy	16,039 +2,700	+20%	+$161K	0.82%	34
2020 Q1	$744K	Buy	+13,339	New	+$815K	0.77%	34

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pavion Blue Capital's BMY Position: Q1 2026 in Review

Pavion Blue Capital reduced its Bristol-Myers Squibb (BMY) stake by 0.18% in Q1 2026, selling an estimated $1.46K and leaving 14,208 shares worth $862K. The position accounts for 0.37% of the portfolio, ranked #54.

Pavion Blue Capital first reported a position in BMY in Q1 2020 and has held it in 25 quarters since. The position peaked at $1.26M in Q2 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Pavion Blue Capital held 14,208 shares of Bristol-Myers Squibb worth $862K as of Q1 2026.
Pavion Blue Capital sold 25 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.46K.
Bristol-Myers Squibb made up 0.37% of Pavion Blue Capital's portfolio in Q1 2026, its #54 holding.
Pavion Blue Capital first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 25 quarters since.
Pavion Blue Capital's Bristol-Myers Squibb position peaked at $1.26M in Q2 2022.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Pavion Blue Capital's 13F filing for Q1 2026, filed 6 May 2026.